LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise. LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise.

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find PharmaFlow Article for Testosterone Undecanoate

    Client Email Product

    Testosterone Undecanoate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    13
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    3
    Other Suppliers

    Other Suppliers

    10
    API REF. PRICE (USD / KG)
    974

    API Market Place

    6
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    9
    Europe

    Europe

    18
    Canada

    Canada

    3
    Australia

    Australia

    1
    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    3
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    3.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    1
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    50

    USFDA Exclusivities

    4
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    19
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • CAPSULE;ORAL - 158MG
    • CAPSULE;ORAL - 198MG
    • CAPSULE;ORAL - 237MG
    • CAPSULE;ORAL - 112.5MG
    • CAPSULE;ORAL - 100MG
    • CAPSULE;ORAL - 150MG
    • CAPSULE;ORAL - 200MG
    • INJECTABLE;INTRAMUSCULAR - 750MG/3ML (250MG/ML)
    BlogBlog
    Full View ScreenFull Screen View

    Haunted: Teva’s $1.2 billion ‘pay-for-delay’ penalty; which companies will get hit next?

    Subscribe
    Haunted: Teva’s $1.2 billion ‘pay-for-delay’ penalty; which companies will get hit next?
     

    Impressions: 3320

    Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total payment of $1.2 billion as part of a ‘pay-for-delay’ settlement reached with the Federal Trade Commission (FTC) last week.  What exactly did Ce...

    https://www.pharmacompass.com/radio-compass-blog/haunted-teva-s-1-2-billion-pay-for-delay-penalty-which-companies-will-get-hit-next

    #Phispers by PHARMACOMPASS
    04 Jun 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    aspen testosterone undecanoate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    pfizer centreone testosterone undecanoate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search